Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesExpanded studies of piperacillin/tazobactam formulations: variations among branded product lots and assessment of 46 generic lots
Diagnostic Microbiology and Infectious Disease, 10/22/09
Moet GJ et al. – Generic substitutions within hospital formularies should consider parameters of in vitro activity, in addition to applied chemical analyses and measures of bioavailability to avoid potential adverse clinical consequences.
Related Articles
Teva Receives Final Approval For Generic Prevacid Delayed-Release Capsules
Teva Pharmaceutical Industries, 11/11/09
Relevance Score: 68%
Cephalon Notified of Generic Filing for Armodafinil Tablets
Cephalon, 10/22/09
Relevance Score: 68%
Mylan Receives FDA Approval for Generic Version of Prevacid Through its Subsidiary Matrix Laboratories
Mylan, 11/11/09
Relevance Score: 67%
APP Pharmaceuticals Receives Approval for the First Generic Chlorothiazide Sodium for Injection, USP
American Pharmaceutical Partners, 10/22/09
Relevance Score: 67%
Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment SinemetÂ
Mylan, 10/01/09
Relevance Score: 67%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Investigational drugs for hepatitis C
Expert Opinion on Investigational Drugs, 12/15/09
Positive urine cultures: A major cause of inappropriate antimicrobial use in hospitals
Canadian Journal of Infectious Diseases, 12/15/09
Treatment of vancomycin-intermediate Staphylococcus aureus (VISA) endocarditis with linezolid
International Journal of Infectious Diseases, 12/15/09
Article Search
Sponsor